Pancreatic glucokinase (GK) is considered an important element of the glucose-sensing unit in pancreatic ␤-cells. It is possible that the brain uses similar glucose-sensing units, and we employed GK immunohistochemistry and confocal microscopy to examine the anatomical distribution of GK-like immunoreactivities in the rat brain. We found strong GK-like immunoreactivities in the ependymocytes, endothelial cells, and many serotonergic neurons. In the ependymocytes, the GK-like immunoreactivity was located in the cytoplasmic area, but not in the nucleus. The GK-positive ependymocytes were found to have glucose transporter-2 (GLUT2)-like immunoreactivities on the cilia. In addition, the ependymocytes had GLUT1-like immunoreactivity on the cilia and GLUT4-like immunoreactivity densely in the cytoplasmic area and slightly in the plasma membrane. In serotonergic neurons, GK-like immunoreactivity was found in the cytoplasm and their processes. The present results raise the possibility that these GK-like immunopositive cells comprise a part of a vast glucose-sensing mechanism in the brain. (Endocrinology 141: [375][376][377][378][379][380][381][382][383][384] 2000) G LUCOSE AVAILABILITY plays a crucial role in regulating feeding behavior (1) and the activity of the reproductive axis (2). In both cases, there is compelling evidence that glucose availability is sensed by the brain. Oomura et al. (3) have found populations of neurons that respond to hyper-or hypoglycemic stimulation in various areas of the brain. Intracellular recordings in the ventromedial and lateral nuclei of the hypothalamus in vivo and in vitro have revealed an increase or decrease in neuronal bursting accompanying local glucose application (4). In addition, lateral ventricular administration of 2-deoxyglucose (2-DG), a glycolysis inhibitor, increases the food intake in rats (5). These findings suggest that the forebrain, especially the hypothalamus, contains a glucose-sensing mechanism. Furthermore, Ritter et al. reported that glucose availability can be sensed by the hindbrain to regulate feeding behavior in their studies in which the aqueduct was occluded by silicon grease before the administration of 5-thioglucose, another glycolytic inhibitor, into either the third or fourth ventricle (6). Local glucoprivation induced in the fourth ventricular region was more effective in inducing feeding behavior than that induced in the third ventricle (6), suggesting that the lower brain stem possesses sensitive glucose-sensing sites involved in the regulation of feeding behavior. Our recent finding that 2-DG administration limited to the fourth ventricle inhibits pulsatile LH secretion also suggests that glucose availability is sensed by glucose sensors in the hindbrain to control GnRH/LH secretion in rats (7). In the medulla oblongata, the area postrema (AP) and the nucleus tractus solitarius (NTS) have been thought to possess the glucose sensors related to feeding and reproduction, based on the findings that the AP/NTS lesion impairs 2-DG-induced feeding in rats (8) and 2-DG-induced suppression of estrous cycles in Syrian hamsters (9). However, the precise localization of glucose sensors or the glucose-sensing mechanism in the brain has not been determined.
G LUCOSE AVAILABILITY plays a crucial role in regulating feeding behavior (1) and the activity of the reproductive axis (2) . In both cases, there is compelling evidence that glucose availability is sensed by the brain. Oomura et al. (3) have found populations of neurons that respond to hyper-or hypoglycemic stimulation in various areas of the brain. Intracellular recordings in the ventromedial and lateral nuclei of the hypothalamus in vivo and in vitro have revealed an increase or decrease in neuronal bursting accompanying local glucose application (4) . In addition, lateral ventricular administration of 2-deoxyglucose (2-DG), a glycolysis inhibitor, increases the food intake in rats (5) . These findings suggest that the forebrain, especially the hypothalamus, contains a glucose-sensing mechanism. Furthermore, Ritter et al. reported that glucose availability can be sensed by the hindbrain to regulate feeding behavior in their studies in which the aqueduct was occluded by silicon grease before the administration of 5-thioglucose, another glycolytic inhibitor, into either the third or fourth ventricle (6) . Local glucoprivation induced in the fourth ventricular region was more effective in inducing feeding behavior than that induced in the third ventricle (6) , suggesting that the lower brain stem possesses sensitive glucose-sensing sites involved in the regulation of feeding behavior. Our recent finding that 2-DG administration limited to the fourth ventricle inhibits pulsatile LH secretion also suggests that glucose availability is sensed by glucose sensors in the hindbrain to control GnRH/LH secretion in rats (7) . In the medulla oblongata, the area postrema (AP) and the nucleus tractus solitarius (NTS) have been thought to possess the glucose sensors related to feeding and reproduction, based on the findings that the AP/NTS lesion impairs 2-DG-induced feeding in rats (8) and 2-DG-induced suppression of estrous cycles in Syrian hamsters (9) . However, the precise localization of glucose sensors or the glucose-sensing mechanism in the brain has not been determined.
Peripheral organs such as pancreas, fat tissue, and the gastrointestinal tract are able to sense the nutritional state and secrete specific hormones to maintain metabolic homeostasis (10) . Among these tissues, ␤-cells in the islets of Langerhans are known to have a glucose-sensing mechanism to secrete insulin in response to increased blood glucose levels. These cells have both a specific subtype of the glucose transporter-2 (GLUT2) and a high K m hexokinase [glucokinase (GK)] (11) (12) (13) . GK is distinguished from other hexokinase by features such as its low affinity for glucose and its lack of inhibition by glucose-6-phosphate (14) . GLUT2 also possesses a high K m constant for glucose (15) . Because pharmacological blockade of GK with mannoheptulose, which is an inhibitor of glucose phosphorylation, suppresses the insulin secretory response to glucose in islets (16) , and mice in which the GK gene is disrupted do not secrete insulin in response to the administration of glucose (17) (18) (19) , GK is considered to play a critical role in sensing blood glucose levels.
As the presence of GK is a prerequisite for glucose sensing in the pancreatic ␤-cells, it is reasonable to postulate that GK also plays a role in glucose sensing in the brain to monitor glucose availability. There is physiological evidence to support the idea that a glucose-sensing mechanism similar to that in pancreatic ␤-cells is localized in the brain. Fourth ventricular injection of alloxan, which inhibits GK activity (20) , causes feeding behavior at the low level (21) and eliminates 2-DG-induced feeding at the high level (8) . However, there are few studies indicating the localization of GK in the brain.
In the present study the immunohistochemical localization of pancreatic GK was determined in the brain, with a focus on the lower brain stem. We paid much attention to the AP and NTS because of their significance in previous reports. We also characterized the GK-like immunoreactive cells in the brain using dual immunohistochemistry with reference to glucose transporters as well as specific cell-type markers. In addition, we examined the subcellular localization of GK-like immunoreactivity using confocal laser microscopy.
Materials and Methods Animals
Female Wistar-Imamichi rats (150 -200 g BW) were housed in a controlled environment (23Ϫ25 C; 14 h of light, 10 h of darkness, with lights on at 0500 h) and provided with food (Labo-MR-stock, Nihon Nosan Kogyo Co, Yokohama, Japan) and water ad libitum. All of the animals that had at least two consecutive 4-day estrous cycles were ovariectomized 2 weeks before the experiment.
Antibodies
A goat antiglucokinase polyclonal antibody raised against a peptide corresponding to amino acids 2-20 of human pancreatic glucokinase (GKP) was used (anti-GKP antibody, 1:25 for immunohistochemistry; Santa Cruz Biotechnology, Inc., Santa Cruz, CA). The rabbit polyclonal antiliver glucokinase (GKL) antibody (1:50) was raised against purified liver GK and has been described previously (22) . The rabbit anti-GLUT2 antibody used (1:2000; Biogenesis, New Fields, UK) was raised against a fusion protein consisting of the C-terminal 25 amino acids of the rat GLUT2, glutathione-S-transferase, and a synthetic 13-amino acid Cterminal sequence of rat GLUT2. We used a rabbit polyclonal antibody to GLUT1 (1:100; Santa Cruz Biotechnology, Inc.) and GLUT4 (1:25; Chemicon International, Inc., Temecula, CA). Other reagents used were a mouse monoclonal antibody to the microtubule-associated protein-2 (MAP2) that recognizes MAP2a, MAP2b, and MAP2c; protein markers of neurons (1:500; Sigma, St. Louis, MO); a rabbit polyclonal antibody to the glial fibrillary acidic protein (GFAP), a protein marker of glial cells (1:10; DAKO Corp., Glostrup, Denmark); a mouse monoclonal antibody to vimentin, a protein marker of ependymocytes (23) 
Fixation
Ten animals were perfused transcardially with 50 ml 0.05 m PBS (pH 7.5) at room temperature followed by 100 ml ice-cold 4% paraformaldehyde in 0.05 m phosphate buffer (PB; pH 7.5) under deep pentobarbital anesthesia. The brain, liver, and pancreas were removed, postfixed by the same fixative overnight at 4 C, and cryoprotected with 30% sucrose in 0.05 m PB for 2-3 days at 4 C. The brain and liver were sectioned at 30-m thickness with a cryostat. The sections were stored in a cryoprotectant at Ϫ20 C until stained. The pancreas was sectioned at 20-m thickness, thaw-mounted on glass slides, dried, and preserved at Ϫ30 C.
The fourth cerebroventricular area collected from five rats was used for whole mount immunostaining. The brain was removed immediately after the decapitation. The dorsal portion of the medulla oblongata including the AP and the NTS was removed under a dissecting microscope. The excised tissues were fixed with 4% paraformaldehyde in 0.05 m PB at 4 C overnight and were rinsed four times for 15 min each time in 0.05 m PBS.
Immunohistochemistry
The localization of the target proteins was determined by immunoperoxidase histochemistry or fluorescence immunohistochemistry. All incubations were carried out at 4 C, and the sections were rinsed four times for 15 min each time with 0.05 m PBS between each step unless otherwise indicated. For immunoperoxidase histochemistry, free floating sections or glass slide-mounted sections were 1) incubated with 0.05 m PBS containing 0.6% H 2 O 2 at room temperature for 30 min to eliminate endogenous peroxidase activity, 2) incubated with the paper-filtrated 10% skim milk in 0.05 m PBS containing 0.05% Triton X-100 for 60 min at room temperature to block nonspecific binding of antibodies, 3) incubated for 4 days under constant shaking with primary antibodies diluted in the same solution used for blocking nonspecific binding of antibodies as described above, 4) incubated with biotinylated secondary antibody for 60 min at room temperature with constant shaking, 5) incubated with the streptavidin-biotin complex solution (Vector Elite ABC kit, Vector Laboratories, Inc.) for 60 min at room temperature. The 4-day incubation period was chosen to lower the background level of immunostaining. Sections were rinsed four times for 15 min each time in 0.1 m Tris-HCl buffer (pH 7.5). The immunoreactivities were visualized by 0.1% 3,3Ј-diaminobenzidine (Sigma) and 0.02% H 2 O 2 solution containing 0.25% NiCl 2 in 0.1 m Tris-HCl buffer in the dark. Free floating sections were mounted on the gelatin-coated glass slides, and all sections were observed under a light microscope (Eclipse E800, Nikon, Tokyo, Japan). The images were directly digitized by a CCD camera (PA-160, Nikon) and printed on a Fuji Pictrography 3000 (Fuji Photo Film Co., Ltd., Tokyo, Japan).
For fluorescence immunohistochemistry, sections were incubated in the same blocking solution used in immunoperoxidase histochemistry after rinsing four times for 15 min each time in 0.05 m PBS. Then, sections were incubated in the primary antibody for 4 days with constant shaking. In dual immunohistochemistry, sections were incubated with a mixture of two primary antibodies. The sections were then rinsed four times for 15 min each time in 0.05 m PBS and incubated with the fluorescence-conjugated secondary antibodies for 2 h in the dark at room temperature. After incubation of the secondary antibody, free floating sections were mounted on glass slides, and all sections were coverslipped with Fluorogard antifade reagent (Bio-Rad Laboratories, Inc., Hercules, CA). They were examined under a confocal laser scanning microscope (MRC 1024, Bio-Rad Laboratories, Inc.).
For whole mount preparations, tissues were incubated in 0.05 m PBS containing 0.5% Triton X-100 overnight to enhance the permeability of antibodies. The sections were immersed in the same blocking solution used in the immunoperoxidase histochemistry overnight. After blocking nonspecific binding, tissues were transferred to the primary antibody solution containing rabbit anti-GLUT2 antibody for 4 days. Tissues were then washed four times for 15 min each time in 0.05 m PBS and incubated with the solution containing Cy3-conjugated donkey antirabbit IgG overnight. After rinsing four times for 15 min each time in 0.05 m PBS, they were mounted on glass slides and covered with Fluorogard and a coverslip. The dorsal view of the three-dimensional digital image was constructed from 100 pieces of sections scanned at 2-m intervals with a confocal laser scanning microscope.
Specificity of immunostaining
To test the specificity of the anti-GKP, 60 l antibody solution containing 1.2 g antibodies were incubated at 4 C overnight with 60 g of the synthetic antigen peptide (Santa Cruz Biotechnology, Inc.). To examine the specificity of anti-GLUT2 antibody, the antibody was adsorbed with the solution containing the rough plasma membrane fraction prepared from rat liver, because the membrane fraction of the liver is rich with GLUT2 (24) . Five grams of the rat liver were homogenated in 20 ml 1 mm NaHCO 3 (pH7.5), filtrated, and diluted with 480 ml 1 mm NaHCO 3 . The homogenate was centrifuged at 1500 ϫ g for 10 min, and 210 ml 1 mm NaHCO 3 was added to the resultant precipitate. The mixture was centrifuged at 100 ϫ g for 5 min and at 1000 ϫ g for 10 min again. The fluffy layer was removed, diluted with 105 ml 1 mm NaHCO 3 , and used as a rough membrane fraction. The protein concentration in this solution (3.61 mg/ml) was measured by the Bio-Rad Laboratories, Inc., protein assay kit in accordance with the Bradford method (25) . The 200 l anti-GLUT2 solution containing 0.02 g antibodies were incubated with 5 l plasma membrane solution at 4 C overnight, and then used for immunohistochemistry.
Results

Localization of pancreatic GK-like immunoreactivity in rat brain
In the lower brain stem, cells comprising the walls of the central canal, fourth ventricle and aqueduct were stained by the anti-GKP antibody (Fig. 1) . In addition, cells surrounding the third and lateral ventricles in the forebrain were also stained by anti-GKP antibody (data not shown). Double staining with anti-GKP and antivimentin antibodies revealed that GKP-like immunoreactive cells on the ventricular walls, such as the central canal (Fig. 1A, white) , the fourth ventricle (Fig. 1B, white) , and the third ventricle (Fig. 1C, white) , were immunoreactive to vimentin. In the dorsal and ventral ends of the central canal (Fig. 1A, right) and the intermediate part of the third ventricle on dorsoventral axis around the hypothalamus (Fig. 1C, right) , the tapering processes of ependymocytes were stained with anti-vimentin antibody, but lacked the GKP-like immunoreactivity (Fig. 1, A and C, left) . There was no GKP immunoreactivity in the ventral one third of the third ventricular wall (data not shown), an area known to be comprised of ependymal tanycytes (26) .
GKP-like immunoreactive cells were observed in several raphe nuclei, including the dorsal raphe nucleus (data not shown), the median raphe nucleus (data not shown), the raphe obscurus (Fig 2, A and B, black) , the raphe pallidus (Fig.  2, A and C, black) , the raphe magnus, and the raphe pontis (data not shown). This immunoreactivity was localized within both soma and dendrite-like processes. Clusters of the GKP-like immunoreactive cells were also located around the ventrolateral medullary surface (Fig. 2, A and D, black) and fourth ventricle (data not shown). Figure 2D shows immunopositive processes that appear adjacent to a blood vessel in the ventrolateral medulla (arrowheads). No immunopositive cells were located in the AP and the NTS (data not shown). In the hypothalamus, no immunoreactivity of GKP was found, except for the ependymocytes and a few small cells near the third ventricle (data not shown). Dual immunostaining with anti-GKP and either anti-MAP2 or anti-GFAP antibodies in the raphe obscurus (Fig. 2, E and F) and the dorsal raphe nucleus (Fig. 2, G and H) identified cells that contain both MAP2-like (E, right, or G, lower) and GKP-like (E, left, or G, upper) immunoreactivities in the cytoplasm and the processes of the cells in both nuclei. On the contrary, GFAP (F, right, or H, lower) immunoreactivity was not colocalized with GKP-like (F, left, or H, upper) immunoreactivity (Fig. 2, F and H) . Colocalization of GKP and MAP2 was also found in other raphe nuclei, including the raphe pallidus (Fig. 2I) . Figure 2J represents a high magnification image of colocalization of the MAP2-and GKP-like immunoreactivities in the raphe obscurus. Vimentin immunoreactivity was not found in the cells of the raphe nuclei (data not shown). These results strongly suggest that these GK-like immunoreactive cells in raphe nuclei are most likely neurons.
Small cells adjacent to blood vessels in the lower brain stem (Fig. 3J ) and hypothalamus (data not shown) were also stained with anti-GKP antibody (green). GLUT1-like immunoreactivity (red) surrounded the wall of microvessels, whereas GKP-like immunoreactivity was seen in the cytoplasm of the cells. These data suggest that the GKP-like immunoreactive cells adjacent to the blood vessels are most likely endothelial cells.
Ependymocytes
Most GKP-like immunoreactive ependymocytes contained GLUT1-, GLUT2-, and GLUT4-like immunoreactivities. GKP-like (green) and GLUT2-like (red) immunoreactivities were found in ciliated ependymocytes (Fig. 3, A-E) . A three-dimensional image of whole mount preparation constructed from the confocal laser scanning microscopic sections revealed that GLUT2-like immunoreactivities were located along the wall of the fourth ventricle (Fig. 3F, white) , but not on the dorsal surface of the AP. GLUT2-like immunoreactivities were located on the cilia (Fig. 3G, black) , whereas GKP-like immunoreactivities were located in the cytoplasmic area (Fig. 3, A-E) . GLUT2-like immunoreactivity was eliminated when the antibody was preincubated with the plasma membrane fraction of rat liver, which are known to be rich with GLUT2 (Fig. 3H) . Similar to the distribution of GLUT2-like immunoreactivity, GLUT1-like immunoreactivity (red) was also found in the cilia of the ependymocytes surrounding the central canal, fourth ventricle, third ventricle (data not shown), and lateral ventricle (Fig. 3I) . The cytoplasmic area of ependymocyte was dually stained with anti-GKP (green) and anti-GLUT4 (red) in both the lower brain stem (Fig. 3K ) and the forebrain (data not shown). Slight GLUT4-like immunoreactivities were also found in the plasma membrane, but not in the cilia or the tapering processes of ependymocytes. The subcellular localization of GLUT4 in ependymocytes is similar to that in skeletal and cardiac muscle fibers, in which the immunoreactivities are located in both the cytoplasmic area and the plasma membrane (data not shown).
Neurons in the raphe nuclei
Results from dual immunohistochemistry using anti-GKP and antiserotonin antibodies in raphe nuclei confirmed that serotonin immunoreactivities were identified in all GKP-like immunoreactive neurons in the raphe nuclei (Fig. 4) . This colocalization includes the raphe obscurus, the raphe pallidus (data not shown), the dorsal raphe nucleus (Fig. 4A,  white) , the median raphe nucleus (Fig. 4B, white) , the raphe magnus, and the raphe pontis (data not shown). The GK-like immunopositive neurons in the ventrolateral part of medulla oblongata also displayed serotonin immunoreactivity (Fig.  4C, arrowheads) . Serotonin immunoreactivity was expressed in both the cytoplasm and processes of these neurons. GKlike immunoreactivity was not found in fine serotonin-immunoreactive fibers, which might be axons. None of these serotonergic neurons was positively stained with anti-GLUT1, anti-GLUT2, or anti-GLUT4 antibodies (data not shown).
Specificity of the anti-GKP antibody
To assess the tissue specificity of the anti-GKP antibody, cryosections of rat pancreas and liver were processed for immunohistochemistry. In the pancreas, many positively stained cells were observed in the islets of Langerhans where immunofluorescence was predominantly cytoplasmic (Fig.  5A, white) . By contrast, no pancreatic GK-like immunoreactivity was found in the liver (Fig. 5B) . Using an anti-GK antibody raised against liver type-GK (anti-GKL) on liver tissue sections, cell nuclei of hepatocytes were intensely fluorescent (Fig. 5C, white) . These subcellular localizations of GK in the islets of Langerhans and hepatocytes are similar to those reported previously (13, 22, 27) , indicating that the FIG. 2 . GK-like immunoreactivity in the raphe nuclei and ventrolateral medulla. The GK-like immunoreactivities were located in the ventral part of medulla (A, immunoperoxidase histochemistry). Insets highlight the positively stained cells (black) in the raphe obscurus (B), the raphe pallidus (C), and the ventrolateral area of medulla (D). Digital images from colocalization studies (GK/MAP2 and GK/GFAP) are shown in E-J. MAP2 (white; E, G, I, and J), but not GFAP (white; F and H), immunoreactivity was located in the GK-like immunopositive (white) cells in the raphe nuclei. Colocalization of MAP2-and GK-like immunoreactivities were detected within the cytoplasm and processes of all GK-like immunopositive cells in the raphe nuclei including the raphe obscurus (E and J) and the dorsal raphe nucleus (G). GFAP immunoreactivities were not colocalized with GK-like immunoreactivity in the cells in raphe obscurus (F) and the dorsal raphe nucleus (H). The GK-and MAP2-like immunoreactivities were also colocalized in the cells of the raphe pallidus (I). Scale bar, 50 m; except A, 100 m.
FIG. 3.
Glucose transporter-like immunoreactivities in GK-like immunopositive ependymocytes and endothelial cells. The GLUT2-like immunoreactivities were detected on the cilia of GK-like immunopositive ependymocytes composing the wall of the central canal (A), the aqueduct (B), the third ventricle (C), the lateral ventricle (D), and the fourth ventricle (E). A three-dimensional image of whole mount preparation constructed from the confocal laser scanning microscopic sections revealed that GLUT2-like immunoreactivities (white) were located along the wall of the fourth ventricle, but not on the dorsal surface of area postrema (F). Precise localization of the GLUT2 (black) on the cilia was revealed by the immunoperoxidase histochemistry (G). GLUT2-like immunoreactivity was eliminated by preincubation of anti-GLUT2 antibody with anti-GKP antibody used in the present study recognizes the pancreatic-type GK, but not the liver-type GK. Positive immunoreactivities observed in the ependymocytes were eliminated by the preadsorption of the anti-GKP antibody with the synthetic peptide derived from the N-terminus of GK of pancreatic type as described in Materials and Methods (Fig. 5D,  white) . No positive immunoreactivity was found in these regions using rabbit anti-GKL raised against the liver-type GK (data not shown). The positive immunoreactivity found in neurons of the raphe nuclei eliminated with preadsorption using the synthesized peptide comprised of the N-terminus of pancreatic-type GK (Fig. 5E, white) .
Discussion
In the present study GK-like immunoreactivity was found in specific cell types of the brain, including ependymocytes, serotonergic neurons, and endothelial cells (Fig. 6) . Ciliated liver membrane fraction (H). GLUT1-like immunoreactivity (red) was also identified on the cilia of the ependymocytes lining the wall of the lateral ventricle (I). The GLUT1-like immunoreactivity (red) was identified in the wall of a microvessel, and GK-like immunoreactivity (green) was present in the cytoplasm (J). GLUT4-like immunoreactivity (red) was colocalized with GK-like immunoreactivity (green) in the cytoplasmic area of ependymocytes surrounding the central canal (K). ependymocytes also contain specific types of glucose transporter immunoreactivities, i.e. GLUT2 and GLUT1 on cilia and GLUT4 predominantly in the cytoplasmic area. In the pancreas, GK is thought to play an important role in glucose sensing, as point mutations in the glucokinase gene produces mice that lack normal insulin secretory responses (17, 18) . Further, homozygous GK null mice cannot survive after birth (19) . GK due to its comparatively lower affinity for glucose creates an intracellular ATP/ADP ratio based upon intercellular glucose levels (11) . It is a change in ATP concentrations in response to increased glucose that is thought to alter the K ϩ -ATP channel, which, in turn, stimulates insulin secretion from the ␤-cells (28) . In this context, the GKP-like immunoreactive cells in the brain, i.e. ependymocytes, sero- In addition to the schema, GK-like immunopositive ependymocytes showed the GLUT2-like and GLUT1-like immunoreactivities on the cilia and the GLUT4-like immunoreactivity predominantly in cytoplasmic area (see Fig. 3 , A-E). Endothelial cells also showed the GLUT1-like immunoreactivity lining the wall of microvessel (see Fig. 3J ). 3V, Third ventricle; 4V, fourth ventricle; AP, area postrema; AQ, aqueduct; CC, central canal; DRn, dorsal raphe nucleus; Hip, hippocampus; LV, lateral ventricle; MRn, median raphe nucleus; RMg, raphe magnus; RO, raphe obscurus; RP, raphe pallidus; RPo, raphe pontis; Sep, septum.
tonergic neurons, and endothelial cells, may represent components of another glucose-sensing system similar to that seen in pancreatic ␤-cells.
No GK-immunopositive cells were found in the AP and the NTS in the present experiment. This was very surprising, because the AP and the NTS have been thought to play an important role in glucose sensing based upon the results that the AP/NTS lesion inhibits the 2-DG-induced feeding (8) and 2-DG-induced suppression of estrous cycles (9) . It might be possible to explain the contradiction that the GK in the AP/ NTS could not be detected by anti-GKP antibody due to its low sensitivity to the GK. If we concur with this explanation, it would be probable that the AP/NTS could sense the glucose level by other mechanisms than GK does. On the other hand, the second explanation that these areas are not glucose sensors but, rather, serve as relay stations for signals sensed elsewhere could not be excluded, because the AP and the NTS are known to receive much sensory input from other ganglia and brain nuclei (8) . The GKP-like immunoreactivity in the hypothalamus as well as the AP/NTS was not detected, except for ependymocytes and few small cells. The hypothalamus has been considered the center of glucose sensing (3), but some reports have found that glucose availability related to feeding and reproduction is mainly sensed by the hindbrain, based upon pharmacological glucoprivation studies (6, 7) . The lack of GKP-like immunoreactivities in the hypothalamic neurons might support the importance of glucose-sensing mechanism in the hindbrain. Physiological experiments will be needed to clarify these points.
Several lines of evidence suggest that ependymocytes play a role in transporting nutrients from the cerebrospinal fluid (CSF) to the underlying neuropil. GKP-like immunoreactivities in ependymocytes in the wall of third cerebroventricle have been described briefly (29) , like our observation in third cerebroventricle. Due to the presence of monocarboxylate transporter-1 and -2, ependymocytes appear capable of transporting lactate and other monocarboxylates (30, 31) . Further, GLUT1-and GLUT2-like immunoreactivities and GLUT4 messenger RNA expression have been identified in ependymocytes (Refs. 32 and 33 and the present results). The presence of GLUT1-and GLUT2-like immunoreactivities on cilia of these ependymocytes, documented in the present study, suggests that these transporters are localized to cell surfaces where efficient transport of glucose would take place. On the other hand, GKP-like immunoreactivity was found in the cytoplasm of GLUT1-or GLUT2-positive ependymocytes as in pancreatic ␤-cells (24) . Given this anatomical localization of glucose transporters and GK, it seems reasonable to propose that glucose would be converted to glucose-6-phosphate (the rate-limiting conversion of glucose to ATP) soon after its entry into the ependymocytes. Taken together, it is possible that ciliated ependymocytes detect metabolic alternations in nutrients in CSF per se. It has been shown that glucose passes from blood to CSF at low affinity with a concentration gradient (34) . The brain, therefore, could monitor the CSF glucose levels to detect the changes in blood glucose levels. The present study also demonstrated that GLUT4-like immunoreactivity was found within the cytoplasm of ependymocytes in ad libitum-fed rats.
It is well established that GLUT4 is located in skeletal muscle and adipose tissue and translocates from cytoplasm to plasma membrane in response to insulin (35) , whereas pancreatic ␤-cells and hepatocytes do not have GLUT4 (24) . Although the precise function of GLUT4 remains to be fully elucidated, it is tempting to speculate that this GLUT4 plays an important role in the transport of glucose from the CSF to the neuropil when insulin concentrations in blood are high and composes part of the insulin-dependent glucose-sensing mechanism.
If ependymocytes serve to sense nutrients in the CSF, how is this system regulated? Some possible counterregulatory processes come from previous evidence demonstrating that particular growth factors suggested to be satiety factors (36, 37) increase in the CSF after feeding or glucose administration (38) . Importantly, fibroblast growth factor I (FGF-I) and FGF-I messenger RNA have been detected in ependymocytes after glucose treatments (38) . Perhaps the ependymocytes send nutritional information to other cells through secretion of specific peptides such as FGF-I.
The present study found that serotonergic neurons in the raphe nuclei contain GK-like immunoreactivities. The serotonergic system is known to be involved in the regulation of feeding behavior. Serotonin-1B and -2C receptor agonists suppress food intake in rats (39) , and mice lacking serotonin-2C receptor display overweight (40) . Furthermore, some reports have suggested that particular raphe nuclei are related to glucose sensing: Dinh et al. demonstrated that food intake increases after a local injection of 5-thioglucose into the ventral medulla in which the raphe obscurus and the raphe pallidus is located (41) . Blood insulin increases when the raphe obscurus is chemically stimulated (42) . Leurope et al. found GLUT2 immunoreactivity in the raphe obscurus (43) . These findings emphasize the importance of raphe obscurus as a glucose-sensing area. On the other hand, peripheral nutritional information might be relayed by the serotonergic neurons in the dorsal raphe nucleus, because the dorsal raphe nucleus has been reported to contain receptors for the fat hormone, leptin (44) . These considerations together with the present results raise the possibility that specific populations of serotonergic neurons are equipped with a glucose-sensing mechanism and therefore may be capable of relaying nutritional information. In the present study a large number of GK-like immunoreactive processes were found closely associated with the blood vessels. In addition, numerous serotonergic fibers have been found to be in contact with CSF and ependymocytes (45) , reinforcing the idea that serotonergic neurons could receive nutritional signals from both blood and CSF.
In conclusion, GK-like immunoreactivity is located in three types of cells in the brain, namely ciliated ependymocytes, serotonergic neurons, and endothelial cells. Ciliated ependymocytes also displayed GLUT2-and GLUT1-like immunoreactivities on the cilia and GLUT4-like immunoreactivity in the cytoplasm. Overall, the present study provides strong evidence for pancreatic GK-like immunoreactivity in the brain being closely associated with glucose-sensing mechanisms.
